BIO-key International (NASDAQ:BKYI) Shares Pass Below Two Hundred Day Moving Average – Here’s Why

BIO-key International Inc. (NASDAQ:BKYI) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.79 and traded as low as $3.71. BIO-key International shares last traded at $3.80, with a volume of 4,290 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Monday, April 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

BIO-key International Trading Down 2.3%

The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17. The firm has a 50 day moving average price of $4.89 and a 200 day moving average price of $5.79. The stock has a market capitalization of $4.12 million, a PE ratio of -0.54 and a beta of 0.44.

BIO-key International (NASDAQ:BKYI) last announced its earnings results on Tuesday, March 31st. The technology company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.70) by $0.51. BIO-key International had a negative return on equity of 67.43% and a negative net margin of 75.32%.The company had revenue of $1.24 million for the quarter, compared to analysts’ expectations of $2.20 million.

Institutional Trading of BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC increased its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Institutional investors own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.